16 September 2020: Clinical Research
Efficacy and Safety of Neuromuscular Blockade in Overweight Patients Undergoing Nasopharyngeal Surgery
Lingxia Niu BCE* , Yu Wang ADEF* , Chunlin Yao B , Yan Sun BF , Shanglong Yao A* , Yun Lin AG*DOI: 10.12659/MSM.926452
Med Sci Monit 2020; 26:e926452
Table 1 Baseline characteristics of the participants.
| Group RS (n=34) | Group RN (n=34) | Group CN (n=34) | P | |
|---|---|---|---|---|
| Age (yr) | 47 (10) | 46 (11) | 43 (10) | 0.314 |
| Height (cm) | 168.8 (7.5) | 168.0 (7.2) | 169.4 (6.5) | 0.723 |
| Weight (kg) | 78.2 (9.7) | 78.2 (9.6) | 79.7 (10.4) | 0.781 |
| BMI (kg/m) | 27.37 (1.97) | 27.61 (2.03) | 27.66 (2.21) | 0.690 |
| Male (%) | 25 (73.5) | 24 (70.6) | 26 (76.5) | 0.860 |
| Mallampati grade I (%) | 18 (52.9) | 16 (47.1) | 16 (47.1) | 0.855 |
| Thyromental distance (cm) | 8.6 (0.8) | 8.2 (0.8) | 8.3 (0.7) | 0.145 |
| ASA status I (%) | 28 (82.4) | 22 (64.7) | 26 (82.4) | 0.236 |
| History of surgical (%) | 16 (47.1) | 22 (64.7) | 20 (58.8) | 0.327 |
| History of smoking (%) | 12 (35.3) | 10 (29.4) | 11 (32.4) | 0.610 |
| Propofol total dose (mg) | 576 (249) | 611 (200) | 511 (194) | 0.158 |
| Remifentanil total dose (mg) | 0.88 (0.48) | 0.94 (0.39) | 0.74 (0.37) | 0.119 |
| Surgery duration (min) | 37 (16) | 41 (15) | 34 (15) | 0.190 |
| Anesthesia duration (min) | 55 (24) | 61 (20) | 53 (20) | 0.250 |
| Data are presented as mean (SD) or number (%); P was used to indicate differences among the 3 groups. BMI – body mass index; ASA – American Society of Anesthesiologists. | ||||